AC Immune Analyst Ratings
AC Immune Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/07/2023 | 436.91% | HC Wainwright & Co. | → $16 | Reiterates | Buy → Buy |
| 06/28/2023 | 436.91% | HC Wainwright & Co. | → $16 | Reiterates | Buy → Buy |
| 05/01/2023 | 436.91% | HC Wainwright & Co. | → $16 | Reiterates | → Buy |
| 04/19/2023 | 436.91% | HC Wainwright & Co. | → $16 | Reiterates | → Buy |
| 03/17/2023 | 436.91% | HC Wainwright & Co. | → $16 | Reiterates | → Buy |
| 07/11/2022 | 235.57% | SVB Leerink | $15 → $10 | Maintains | Outperform |
| 12/20/2021 | 403.36% | SVB Leerink | $17 → $15 | Maintains | Outperform |
| 03/24/2021 | 436.91% | HC Wainwright & Co. | $11 → $16 | Maintains | Buy |
| 12/10/2019 | 269.13% | HC Wainwright & Co. | $8 → $11 | Reiterates | → Buy |
| 02/01/2019 | — | UBS | Downgrades | Buy → Neutral | |
| 11/13/2018 | 504.03% | Leerink Swann | → $18 | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 08/07/2023 | 436.91% | HC Wainwright & Co. | → 16 美元 | 重申 | 購買 → 購買 |
| 06/28/2023 | 436.91% | HC Wainwright & Co. | → 16 美元 | 重申 | 購買 → 購買 |
| 05/01/2023 | 436.91% | HC Wainwright & Co. | → 16 美元 | 重申 | → 購買 |
| 04/19/2023 | 436.91% | HC Wainwright & Co. | → 16 美元 | 重申 | → 購買 |
| 03/17/2023 | 436.91% | HC Wainwright & Co. | → 16 美元 | 重申 | → 購買 |
| 2022 年 11 月 7 日 | 235.57% | SVB Leerink | 15 美元 → 10 美元 | 維護 | 跑贏大盤 |
| 2021 年 12 月 20 日 | 403.36% | SVB Leerink | 17 美元 → 15 美元 | 維護 | 跑贏大盤 |
| 2021 年 3 月 24 日 | 436.91% | HC Wainwright & Co. | 11 美元 → 16 美元 | 維護 | 購買 |
| 2019 年 10 月 12 日 | 269.13% | HC Wainwright & Co. | 8 美元 → 11 美元 | 重申 | → 購買 |
| 02/01/2019 | — | 瑞銀（UBS） | 降級 | 買入 → 中性 | |
| 11/13/2018 | 504.03% | Leerink Swann | → 18 美元 | 啓動覆蓋開啓 | → 跑贏大盤 |
What is the target price for AC Immune (ACIU)?
AC Immune (ACIU) 的目標價格是多少？
The latest price target for AC Immune (NASDAQ: ACIU) was reported by HC Wainwright & Co. on August 7, 2023. The analyst firm set a price target for $16.00 expecting ACIU to rise to within 12 months (a possible 436.91% upside). 5 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2023年8月7日公佈了AC Immune（納斯達克股票代碼：ACIU）的最新目標股價。這家分析公司將目標股價定爲16.00美元，預計ACIU將在12個月內升至16.00美元（可能上漲436.91％）。去年有5家分析公司公佈了評級。
What is the most recent analyst rating for AC Immune (ACIU)?
分析師對AC Immune (ACIU) 的最新評級是多少？
The latest analyst rating for AC Immune (NASDAQ: ACIU) was provided by HC Wainwright & Co., and AC Immune reiterated their buy rating.
AC Immune（納斯達克股票代碼：ACIU）的最新分析師評級由HC Wainwright & Co. 提供，AC Immune 重申了他們的買入評級。
When is the next analyst rating going to be posted or updated for AC Immune (ACIU)?
AC Immune (ACIU) 的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of AC Immune, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for AC Immune was filed on August 7, 2023 so you should expect the next rating to be made available sometime around August 7, 2024.
分析師在進行了廣泛的研究，包括瀏覽公開財務報表、與AC Immune的高管和客戶交談以及聽取業績電話會議後得出股票評級。大多數分析師每三個月進行一次評級，因此每家公司每年應該獲得4個評級。AC Immune 的最新評級是在2023年8月7日提交的，因此你應該預計下一個評級將在2024年8月7日左右公佈。
Is the Analyst Rating AC Immune (ACIU) correct?
分析師對 AC 免疫力 (ACIU) 的評級是否正確？
While ratings are subjective and will change, the latest AC Immune (ACIU) rating was a reiterated with a price target of $0.00 to $16.00. The current price AC Immune (ACIU) is trading at is $2.98, which is within the analyst's predicted range.
雖然評級是主觀的，會發生變化，但最新的AC Immune（ACIU）評級得到了重申，目標股價爲0.00美元至16.00美元。AC Immune（ACIU）目前的交易價格爲2.98美元，在分析師的預測區間內。